Ignite Creation Date:
2025-12-24 @ 6:49 PM
Ignite Modification Date:
2026-03-03 @ 12:58 PM
Study NCT ID:
NCT06189157
Status:
RECRUITING
Last Update Posted:
2025-11-26
First Post:
2023-11-22
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
MB-CART19.1 in Refractory SLE
Sponsor:
Miltenyi Biomedicine GmbH
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
M-2022-398
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None